Related Experiment Video
Updated: Apr 3, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Coccidioidomycosis: Recent Updates
Meryl Twarog1, George R Thompson1
1Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Davis, California.
Abstract:
Coccidioidomycosis manifests as a variety of clinical manifestations and ranges in severity from asymptomatic exposure with resultant immunity to reinfection, to fulminant, and life-threatening disseminated disease. Primary coccidioidal pneumonia represents the most common clinical form of infection, and the incidence continues to increase. Within the endemic region, primary pulmonary coccidioidomycosis represents up to 29% of all community-acquired pneumonia emphasizing the frequency with which clinicians encounter this endemic mycosis. Chronic infection develops in 3 to 5% of patients, and almost all morbidity and mortality observed in coccidioidomycosis occur in these forms (e.g., chronic pulmonary disease, extrapulmonary manifestations). This review summarizes the ecology, epidemiology, manifestations of disease, and treatment options currently available for coccidioidomycosis.
Insights
Coccidioidomycosis, a fungal infection, presents diverse clinical forms, from asymptomatic cases to severe disseminated disease. Primary pulmonary coccidioidomycosis is common and increasing, with chronic infections causing most severe outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- Coccidioidomycosis presents a spectrum of clinical manifestations, from asymptomatic infection to life-threatening disseminated disease.
- Primary pulmonary coccidioidomycosis is the most frequent clinical form, with increasing incidence.
- Chronic infections, occurring in 3-5% of patients, account for nearly all coccidioidomycosis morbidity and mortality.
Purpose of the Study:
- To review the ecology, epidemiology, clinical manifestations, and current treatment options for coccidioidomycosis.
Main Methods:
- This review synthesizes existing literature on coccidioidomycosis.
- Information on ecology, epidemiology, disease presentation, and treatment was compiled.
Main Results:
- Coccidioidomycosis exhibits diverse clinical presentations, including asymptomatic infection, primary pulmonary disease, and disseminated forms.
- Primary pulmonary coccidioidomycosis is a significant cause of community-acquired pneumonia in endemic areas.
- Chronic pulmonary and extrapulmonary manifestations are associated with severe disease and mortality.
Conclusions:
- Coccidioidomycosis is an increasingly prevalent endemic mycosis with a wide range of clinical outcomes.
- Understanding its ecology, epidemiology, and varied manifestations is crucial for effective management.
- Current treatment strategies aim to manage acute and chronic forms of the disease.
More Related Videos
Related Concept Videos
Antifungal Agents
Fungal Phylum Microsporidia
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease
Fungal Group Zygomycota
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

